Concepedia

Oral Alpan

OA

Statistics

Publications

23

Citations

3.4K

H-Index

19

Active since

2001

Affiliations

O&O Alpan (United States)(Current)

Lysosomal and Rare Disorders Research and Treatment Center

Cornell University

SUNY Downstate Health Sciences University

Weill Cornell Medicine

Oral Alpan is an author at O&O Alpan (United States) specializing in immunology, life sciences, and clinical immunology.

Publications per year

2001–2023

23

Publications

23

Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy

Nicola A. Hanania, Oral Alpan, Daniel L. Hamilos et al. · Annals of Internal Medicine · 2011 · 550 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study

Sarbjit S. Saini, Carsten Bindslev‐Jensen, Marcus Maurer et al. · Journal of Investigative Dermatology · 2014 · 460 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +11

2023 ACR/EULAR antiphospholipid syndrome classification criteria

Medha Barbhaiya, Stéphane Zuily, Ray Naden et al. · Annals of the Rheumatic Diseases · 2023 · 424 citations · Full text

Life Sciences, Hematology, Internal Medicine +17

Symptoms Have Modest Accuracy in Detecting Endoscopic and Histologic Remission in Adults With Eosinophilic Esophagitis

Ekaterina Safroneeva, Alex Straumann, Michael Coslovsky et al. · Gastroenterology · 2015 · 328 citations · Full text

Medicine, Clinical Sciences, Pathology +14

Intravenous anti–IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis

Marc E. Rothenberg, Ting Wen, Allison Greenberg et al. · Journal of Allergy and Clinical Immunology · 2014 · 306 citations

Medicine, Immunology, Pharmacology +12

1–5 of 23